Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of fluoxetine and venlafaxine in the mouse neural embryonic stem cell test

ABSTRACT: Effects of fluoxetine and venlafaxine in the mouse neural embryonic stem cell test

PROVIDER: PRJNA644338 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12151300.fastq.gz	Fastqsanger.gz
	SRR12151301.fastq.gz	Fastqsanger.gz
	SRR12151302.fastq.gz	Fastqsanger.gz
	SRR12151303.fastq.gz	Fastqsanger.gz
	SRR12151304.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 49

Similar Datasets

Effects of fluoxetine and venlafaxine in the mouse neural embryonic stem cell test

Project description:The neural embryonic stem cell test (ESTn) is in vitro test that mimics early neural differentiation. The aim of this study was to define the biological domain of ESTn based on gene expression of selective markers for certain cell types, and to investigate the effects of two antidepressants, fluoxetine (FLX) and venlafaxine (VNX), on neural differentiation.

2021-02-27 | GSE153836 | GEO

Effects of five developmental neurotoxicants on neuronal differentiation of human embryonic stem cell derived neural progenitors

Project description:Neuronal differentiation of human embryonic stem cells (hESC) is a promising tool to assess developmental neurotoxicity (DNT) in an animal-free manner. We analysed the transcriptomic profiles of hESC-derived neural progenitors (NPCs) and neuron-astrocyte co-cultures differentiated for 10 days from these same NPCs to identify the most dominant biological processes during neuronal differentiation. In addition, we exposed the NPCs for 10 days to five known or suspected neurodevelopmental toxicants: acrylamide, chlorpyrifos, fluoxetine, methyl mercury or valproic acid at non-cytotoxic (IC20/100) and slightly cytotoxic (IC5) levels. Each compound and concentration revealed unique transcriptomic changes that showed some of the known in vivo mechanisms of these compounds. This study provides evidence that this assay, the human neural progenitor test (hNPT) can be pivotal, together with other animal-free methods, to assess chemical-induced DNT in vitro.

2021-06-01 | GSE166297 | GEO

The antidepressant fluoxetine elicits anticancer effects by impairing aerobic glycolysis in colon cancer cells and xenografts.

Project description:Colon cancer is one of the most common tumors worldwide. Recent reports showed that patients treated with the antidepressant fluoxetine had reduced colon cancer risk, with effects similar to the chemotherapeutic 5-fluoro-uracil. Here, we examined the effects of fluoxetine and 5-fluoro-uracil on gene expression of HT29 colon cancer cell xenografts. HT29 xenografts in NOD/SCID mice were treated with vehicle (physiological solution), fluoxetine (30mg/kg/day), or 5-Fluoro-uracil (50 mg/kg/day).

2015-06-09 | E-GEOD-51904 | biostudies-arrayexpress

The antidepressant fluoxetine elicits anticancer effects by impairing aerobic glycolysis in colon cancer cells and xenografts.

2015-06-09 | GSE51904 | GEO

Neural embryonic stem cell (ESTn) test dose-responses of Valproic Acid, Cyproconazole and Hexaconazole in the neural embryonic stem cell test.

Project description:Effects of Valproic Acid, Cyproconazole and Hexaconazole on stem cell neural development.

2012-07-17 | E-TABM-1205 | biostudies-arrayexpress

Neural embryonic stem cell (ESTn) test dose-responses of six compounds.

Project description:Effects of six compounds on stem cell neural development.

2012-11-08 | E-TABM-1216 | biostudies-arrayexpress

Effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

Project description:The overall goal of this study is the test the effect of 5-HT and fluoxetine on Turicibacter sanguinis gene expression in vitro

2019-07-04 | GSE133810 | GEO

Development of a Neural Teratogenicity Test Based on Human Embryonic Stem Cells- Response to Retinoic Acid Exposure

Project description:The aim of this study was the development of an alternative testing method based on human embryonic stem cells for prenatal developmental toxicity with particular emphasis on early neural development. To this purpose, we designed an in vitro protocol based on the generation of neural rosettes, representing the in vitro counterpart of the developing neural plate and neural tube, and we challenged this complex cell model with retinoic acid (RA), a well-known teratogenic agent. The cells were exposed to different concentrations of RA during the process of rosettes formation. Morphological and molecular parameters were evaluated in treated as compared with untreated cells to detect both cytotoxicity and specific neural toxicity. Transcriptomic analysis was performed with microarray Affymetrix platform and validated by quantitative real-time PCR for genes relevant to early neural development such as HoxA1, HoxA3, HoxB1, HoxB4, FoxA2, FoxC1, Otx2, and Pax7. The results obtained demonstrated that neural rosette forming cells respond to RA with clear concentration-dependent morphological, and gene expression changes remarkably similar to those induced in vivo, in the developing neural tube, by RA exposure. This strict correspondence indicates that the neural rosette protocol described is capable of detecting specific teratogenic mechanisms causing perturbations of early neural development and therefore represents a promising alternative test for human prenatal developmental toxicity.

2012-03-13 | E-MEXP-3577 | biostudies-arrayexpress

Ecotoxicological effects of ketoprofen and fluoxetine and their mixture at microcosm scale on aquatic communities

Project description:Ecotoxicological effects of ketoprofen and fluoxetine

| PRJEB63379 | ENA

Integrative multi-omics landscape of fluoxetine action across 27 brain regions

Project description:We constructed a comprehensive multi-omics map of the molecular effects of fluoxetine (an SSRI antidepressant), in 27 rat brain regions. We profiled gene expression (bulk RNA-seq, 210 datasets) and chromatin state (bulk chromatin immunoprecipitation sequencing (ChIP-seq) for the histone marker H3K27ac, 100 datasets) in a broad, unbiased panel of 27 brain regions across the entire rodent brain, in naive and fluoxetine-treated animals. We complemented this approach with single-cell RNA-seq (scRNA-seq) analysis of two brain regions. Using diverse integrative data analysis techniques we characterized the complex and multifaceted effects of fluoxetine on region-specific and cell-type-specific gene regulatory networks and pathways. Remarkably, we observed profound molecular changes across the brain (>4,000 differentially expressed genes and differentially acetylated ChIP-seq peaks each) that were highly region-dependent. We leveraged this atlas to identify fluoxetine-moduated genes and gene-regulatory loci, predict enriched motifs that suggest potential upstream regulators, and validate global mechanisms of fluoxetine action.

2022-09-04 | GSE193040 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data